[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Rhinovirus Infections - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Rhinovirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rhinovirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 57 pages

Women Infertility - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 232 pages

Uveitis - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Uveitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 266 pages

Axillary Hyperhidrosis - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 59 pages

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2020

US$ 2,000.00

... . The Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Hypoactive Sexual Desire Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 56 pages

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020

US$ 2,000.00

... . The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 140 pages

Arterial Thrombosis - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 40 pages

Contact Dermatitis - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 47 pages

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2020

US$ 2,000.00

... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 80 pages

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H2 2020

US$ 2,000.00

... . The Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

September 2020 163 pages

Uveal Melanoma - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Uveal Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Uveal Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 331 pages

Alcoholic Hepatitis - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 103 pages

Hand, Foot and Mouth Disease - Pipeline Review, H2 2020

US$ 2,000.00

... . The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...

September 2020 43 pages

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020

US$ 2,000.00

... . The Resistant Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Resistant Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 57 pages

Liver Transplant Rejection - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 73 pages

Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2020

US$ 2,000.00

... . The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 70 pages

Achondroplasia - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 66 pages

Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 102 pages

Drug Overdose - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 79 pages

Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2020

US$ 2,000.00

... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 209 pages

Hypopharyngeal Cancer - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Hypopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hypopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

September 2020 495 pages

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2020

US$ 2,000.00

... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 270 pages

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020

US$ 2,000.00

... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 192 pages

Influenzavirus B Infections - Pipeline Review, H2 2020

US$ 2,000.00

... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 182 pages

Malignant Pleural Effusion - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 50 pages

Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020

US$ 2,000.00

... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

September 2020 112 pages

Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2020

US$ 2,000.00

... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 35 pages

Heavy Metal Poisoning - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2020 36 pages

Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2020

US$ 2,000.00

... Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

September 2020 119 pages

Hemophilia B (Factor IX Deficiency) - Pipeline Review, H2 2020

US$ 2,000.00

Hemophilia B (Factor IX Deficiency) - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia B - Pipeline Review, H2 2020, prov...

September 2020 159 pages

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020

US$ 2,000.00

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemo...

September 2020 342 pages

5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020

US$ 3,500.00

5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020'; 5-Hydroxytryptamine Receptor...

September 2020 49 pages

5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020

US$ 3,500.00

5-Hydroxytryptamine Receptor 7 - Pipeline Review, H2 2020 SUMMARY 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) pipeline Target constitutes close to 13 molecules. Out...

September 2020 76 pages

Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020

US$ 3,500.00

Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020 SUMMARY Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) pipeline Target constitutes close to 27 molecules....

September 2020 122 pages

C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020

US$ 3,500.00

C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2020 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 9 molecules. Out of which approximately 8 mo...

September 2020 55 pages

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 - Pipeline Review, H2 2020

US$ 3,500.00

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 - Pipeline Review, H2 2...

September 2020 48 pages

Heparanase - Pipeline Review, H2 2020

US$ 3,500.00

Heparanase - Pipeline Review, H2 2020 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 m...

September 2020 58 pages

High Mobility Group Protein B1 - Pipeline Review, H2 2020

US$ 3,500.00

High Mobility Group Protein B1 - Pipeline Review, H2 2020 SUMMARY High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) - High mobility group box...

September 2020 50 pages

Actinic (Solar) Keratosis - Pipeline Review, H2 2020

US$ 2,000.00

Actinic (Solar) Keratosis - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Actinic (Solar) Keratosis - Pipeline Review, H2 2020, p...

September 2020 69 pages

Bromodomain Testis Specific Protein - Pipeline Review, H2 2020

US$ 3,500.00

Bromodomain Testis Specific Protein - Pipeline Review, H2 2020 SUMMARY Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) - Bromodomain testis-specific protein...

September 2020 57 pages

Calcitonin Gene Related Peptide - Pipeline Review, H2 2020

US$ 3,500.00

Calcitonin Gene Related Peptide - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Calcitonin Gene Related Peptide - Pipeline Review, H2 2020'; Calcitonin Gene Related Pept...

September 2020 96 pages

Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 - Pipeline Review, H2 2020

US$ 3,500.00

Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 - Pipeline Review, H2 2020 SUMMARY Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 (GABA(A) Receptor Subunit Alpha 3 or GABRA3) - Gamma-aminobutyric a...

September 2020 33 pages

Alzheimer's Disease - Pipeline Review, H2 2020

US$ 2,500.00

... . The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 1785 pages

Dyslipidemia - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Dyslipidemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dyslipidemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 345 pages

Epilepsy - Pipeline Review, H2 2020

US$ 2,000.00

... . The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 662 pages

Atrial Fibrillation - Pipeline Review, H2 2020

US$ 2,000.00

... latest pipeline guide Atrial Fibrillation - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Atrial Fibrillation (Cardiovascular) List of TablesNumber of Products under Development for Atrial Fibrillation, H2 2018 9Number of Products under Development ...

August 2020 134 pages

Duchenne Muscular Dystrophy - Pipeline Review, H2 2020

US$ 2,000.00

... . The Duchenne Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 413 pages

Genital Herpes - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Genital Herpes (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Genital Herpes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 123 pages

Osteoarthritis - Pipeline Review, H2 2020

US$ 2,000.00

... releases. The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2020 384 pages

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020

US$ 2,000.00

... . The Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

August 2020 184 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers